Denali Therapeutics (DNLI)
(Delayed Data from NSDQ)
$30.91 USD
-0.14 (-0.45%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $30.90 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.61 |
EPS Last Quarter | -0.59 |
Last EPS Surprise | 13.24% |
ABR | 1.13 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.54 |
Next Year | -2.71 |
EPS (TTM) | -2.85 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.20M | 18.70M | 36.58M | 105.69M |
# of Estimates | 5 | 5 | 6 | 6 |
High Estimate | 33.00M | 27.00M | 45.00M | 175.00M |
Low Estimate | 9.00M | 7.00M | 20.00M | 41.00M |
Year ago Sales | 1.27M | 0.00M | 330.53M | 36.58M |
Year over Year Growth Est. | 1,569.29% | NA | -88.93% | 188.89% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.61 | -0.66 | -2.54 | -2.71 |
# of Estimates | 11 | 10 | 13 | 11 |
Most Recent Consensus | -0.62 | -0.75 | -2.62 | -2.80 |
High Estimate | -0.45 | -0.46 | -2.16 | -2.35 |
Low Estimate | -0.74 | -0.76 | -2.76 | -3.23 |
Year ago EPS | -0.72 | -0.86 | -1.06 | -2.54 |
Year over Year Growth Est. | 15.28% | 23.26% | -139.62% | -6.73% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 7 | 6 | 10 | 9 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 3 |
Down Last 60 Days | 2 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.61 | -0.66 | -2.54 | -2.71 |
7 Days Ago | -0.61 | -0.66 | -2.54 | -2.71 |
30 Days Ago | -0.61 | -0.66 | -2.54 | -2.70 |
60 Days Ago | -0.67 | -0.70 | -2.77 | -2.82 |
90 Days Ago | -0.69 | -0.69 | -2.78 | -2.86 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.61 | -0.66 | -2.54 | -2.70 |
Zacks Consensus Estimate | -0.61 | -0.66 | -2.54 | -2.71 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.12% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.59 | -0.68 | -0.86 | -0.72 | NA |
Estimate | -0.68 | -0.67 | -0.82 | -0.83 | NA |
Difference | 0.09 | -0.01 | -0.04 | 0.11 | 0.04 |
Surprise | 13.24% | -1.49% | -4.88% | 13.25% | 5.03% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more